| * Molecular Immunohaematology Laboratory, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan; Division of Hematology, Ospedali Riuniti di Bergamo, Italy M Introna, J Golay, T Barbui Blood 98, 3383-9, 2001 | | 2001 |
| A comprehensive report of long-term stability data for a range ATMPs: a need to develop guidelines for safe and harmonized stability studies C Capelli, S Frigerio, D Lisini, S Nava, G Gaipa, D Belotti, B Cabiati, ... Cytotherapy 24 (5), 544-556, 2022 | 8 | 2022 |
| A HIV-1 Pol gene derived sequence increases the efficiency of transduction of human acute lymphoblastic leukemia cells by lentiviral vectors. M Introna, E Biagi, M Bonamino, E Todisco, J Golay, A Biondi BLOOD 98 (11), 404B-404B, 2001 | | 2001 |
| A Human Immunodeficiency Virus Type 1 pol Gene-Derived Sequence (cPPT/CTS) Increases the Efficiency of Transduction of Human Nondividing Monocytes and … M Manganini, M Serafini, F Bambacioni, C Casati, E Erba, A Follenzi, ... Human gene therapy 13 (15), 1793-1807, 2002 | 67 | 2002 |
| A multicenter Phase II study of sequential administration of unmanipulated DLI and donor derived Cytokine Induced Killer (CIK) cells in HSCT patients, relapsed of disease M Introna, E Gotti, M Bonzi, J Golay, A Algarotti, C Micò, A Grassi, ... Blood 126 (23), 3160, 2015 | 4 | 2015 |
| A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy J Golay, A D’Amico, G Borleri, M Bonzi, R Valgardsdottir, R Alzani, ... The Journal of Immunology 193 (9), 4739-4747, 2014 | 34 | 2014 |
| A NOVEL, MULTI-SITE GMP PROTOCOL TO MANUFACTURE PROSPECTIVELY-ISOLATED, ALLOGENEIC BONE MARROW MSCS FOR A PHASE 1B CLINICAL TRIAL IN PROGRESSIVE DIABETIC KIDNEY DISEASE H Roelofs, E Steeneveld, O Pedrini, J Golay, A Duffy, V McInerney, ... CYTOTHERAPY 24 (5), S51-S51, 2022 | | 2022 |
| A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma M Galli, S Salmoiraghi, J Golay, A Gozzini, C Crippa, N Pescosta, ... Annals of hematology 89, 185-190, 2010 | 118 | 2010 |
| A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results. M Galli, S Salmoiraghi, J Golay, A Gozzini, A Bosi, C Crippa, G Rossi, ... Blood 110 (11), 1175, 2007 | 21 | 2007 |
| A phase II multiple dose clinical trial of historic deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma: Preliminary results M Galli, S Salmoiraghi, J Golay, A Gozzini, A Bosi, C Crippa, G Rossi, ... Blood 110 (11), 356A-356A, 2007 | 4 | 2007 |
| A phase II study of sequential administration of DLI and cytokine induced killer (CIK) cells in patients with hematologic malignancies relapsing after allogeneic hematopoietic … M Introna, A Algarotti, C Micò, A Grassi, A Pievani, G Borleri, J Golay, ... Blood 118 (21), 657, 2011 | 4 | 2011 |
| A simple and rapid method to analyze specific mRNAs from few cells in a semi-quantitative way using the polymerase chain reaction. J Golay, F Passerini, M Introna Genome Research 1 (2), 144-145, 1991 | 20 | 1991 |
| A single point mutation in the v-ets oncogene affects both erythroid and myelomonocytic cell differentiation J Golay, M Introna, T Graf Cell 55 (6), 1147-1158, 1988 | 113 | 1988 |
| A-Myb is an antiapoptotic factor in t (14; 18) lymphomas through the up-regulation of bcl-2. CA Heckman, JW Mehew, J Golay, M Introna, LM Boxer BLOOD 92 (10), 591A-591A, 1998 | | 1998 |
| A-myb rescues murine B-cell lymphomas from IgM-receptor–mediated apoptosis through c-myctranscriptional regulation M Arsura, CS Hofmann, J Golay, M Introna, GE Sonenshein Blood, The Journal of the American Society of Hematology 96 (3), 1013-1020, 2000 | 29 | 2000 |
| A-Myb up-regulates Bcl-2 through a Cdx binding site in t (14; 18) lymphoma cells CA Heckman, JW Mehew, GG Ying, M Introna, J Golay, LM Boxer Journal of Biological Chemistry 275 (9), 6499-6508, 2000 | 80 | 2000 |
| Acknowledgment to Reviewers of Antibodies in 2020 J Adolf-Bryfogle, S Devasundaram, A Åhlin, D Devaurs, MK Alam, S Dixit, ... | | 2021 |
| Acquired immunodeficiency syndrome‐associated lymphomas are efficiently lysed through complement‐dependent cytotoxicity and antibody‐dependent cellular cytotoxicity by rituximab J Golay, R Gramigna, V Facchinetti, D Capello, G Gaidano, M Introna British journal of haematology 119 (4), 923-929, 2002 | 60 | 2002 |
| Acute Lymphoblastic Leukaemia Cells Carrying the t (12; 21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis. J Golay, C Cortiana, G Cazzaniga, A Salvi, M Manganini, O Spinelli, ... Blood, The Journal of the American Society of Hematology 106 (11), 872-872, 2005 | 1 | 2005 |
| Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia S Loisel, PA André, J Golay, F Buchegger, J Kadouche, M Cérutti, ... Molecular cancer 10, 1-12, 2011 | 21 | 2011 |
